https://www.aafp.org/afp/2019/0801/p185
More Evidence Against Antibiotics for Acute Asthma Exacerbations | AFP
Antibiotics do not benefit patients hospitalized with an asthma exacerbation. Evidence from this study suggests worse outcomes with antibiotic use, including a...
more evidenceacute asthmaantibioticsafp
https://www.amgen.com/newsroom/press-releases/2017/09/tezepelumab-significantly-reduced-asthma-exacerbations-for-a-broad-population-of-patients-with-severe-uncontrolled-asthma
Tezepelumab Significantly Reduced Asthma Exacerbations For A Broad Population Of Patients With...
asthma exacerbations
https://www.sciencedaily.com/releases/2014/05/140520122953.htm
Elevated blood eosinophil levels are risk factor for asthma exacerbations | ScienceDaily
In adults with persistent asthma, elevated blood eosinophil levels may be able to predict which individuals are at increased risk for exacerbations, according...
risk factorasthma exacerbationselevatedbloodeosinophil
https://www.upmc.com/media/news/042821-hill-sw-coke-fire-asthma-jaci
Asthma Exacerbations Followed Christmas Eve Coke Works Fire
Pitt study finds half of people with asthma living near Clairton Coke Works weren't aware of pollution following the Christmas Eve fire.
asthma exacerbationschristmas evecoke worksfollowedfire
https://www.amgen.com/newsroom/press-releases/2021/09/new-tezepelumab-data-show-86-reduction-in-exacerbations-in-patients-with-severe-asthma-and-comorbid-nasal-polyps
New Tezepelumab Data Show 86% Reduction In Exacerbations In Patients With Severe Asthma And...
https://www.gsk.com/en-gb/media/press-releases/depemokimab-late-breaking-data-presented-at-ers-show-a-54-reduction-in-severe-asthma-exacerbations/
Depemokimab late-breaking data presented at ERS show a 54% reduction in severe asthma exacerbations...
SWIFT-1 and SWIFT-2 phase III data show depemokimab delivered statistically significant and clinically meaningful reduction in exacerbations